These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16341811)

  • 21. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
    Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
    J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
    Murthy SS; Testa JR
    J Cell Physiol; 1999 Aug; 180(2):150-7. PubMed ID: 10395284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of malignant pleural mesothelioma.
    Jaurand MC; Fleury-Feith J
    Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Family mesotheliomas: genetic interaction with environmental carcinogenic exposure?].
    You B; Blandin S; Gérinière L; Lasset C; Souquet PJ
    Bull Cancer; 2007 Jul; 94(7):705-10. PubMed ID: 17723954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
    Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
    Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
    J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene.
    Stemmer-Rachamimov AO; Horgan MA; Taratuto AL; Munoz DG; Smith TW; Frosch MP; Louis DN
    J Neuropathol Exp Neurol; 1997 May; 56(5):485-9. PubMed ID: 9143261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
    Baser ME; Makariou EV; Parry DM
    J Neurosurg; 2002 Feb; 96(2):217-22. PubMed ID: 11838793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
    Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
    Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
    Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
    J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
    Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
    Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
    Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
    Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
    Kehrer-Sawatzki H; Udart M; Krone W; Baden R; Fahsold R; Thomas G; Schmucker B; Assum G
    Hum Genet; 1997 Jul; 100(1):67-74. PubMed ID: 9225971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis.
    Sestini R; Provenzano A; Bacci C; Orlando C; Genuardi M; Papi L
    Genet Test; 2008 Jun; 12(2):311-8. PubMed ID: 18554169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
    Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
    J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.
    Schroeder RD; Angelo LS; Kurzrock R
    Oncotarget; 2014 Jan; 5(1):67-77. PubMed ID: 24393766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
    Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
    Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
    Yoo SJ; Hwang YS
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional inactivation of NF2/merlin in human mesothelioma.
    Thurneysen C; Opitz I; Kurtz S; Weder W; Stahel RA; Felley-Bosco E
    Lung Cancer; 2009 May; 64(2):140-7. PubMed ID: 18835652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.